Stocks making the biggest moves premarket: Pfizer, Mylan, BlackRock, Domino's & more
for $2.8 billion in cash and stock. The deal will strengthen Exact Sciences' lineup of cancer testing products.
Exact Sciences also issued its quarterly numbers this morning, losing 30 cents per share compared to a consensus estimate of a 56 cent loss. The maker of the Cologuard colon cancer test also reported revenue that exceeded Street forecasts.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Pfizer Nears Deal to Combine off-Patent Drug Business With MylanPfizer is in talks to merge its off-patent drugs business with generic drugmaker Mylan, in a deal that would create a giant global seller of lower-priced medicines.
Read more »
Pfizer in talks to merge off-patent drugs business with MylanPfizer Inc is in talks to merge its off-patent drugs business with Mylan NV in a...
Read more »
Pfizer in talks to merge off-patent drugs business with Mylan: sourcePfizer Inc is in talks to merge its off-patent drugs business with Mylan NV in a...
Read more »
Pfizer and Mylan reportedly near merger deal for low-priced drugsOne company makes Xanax and Viagra. The other makes the popular EpiPen drug for people with allergies. Now they may be close to merging.
Read more »
Pfizer plans combination of off-patent drug business with MylanThe deal, expected to be announced Monday, will result in Pfizer shareholders owning most of the new company with Mylan's shareholders owning slightly more than 40%.
Read more »
Asia stocks set to trade lower as US-China trade talks resumeStocks in Asia were set to trade lower on Monday as U.S.-China talks resume in Beijing later this week amid low expectations for a major breakthrough.
Read more »